Quick Answer
vTv Therapeutics Inc. reported Net Income of -$26.97 million for fiscal year 2025.
vTv Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$26.97M | -46.1% |
| 2024 | -$18.46M | +8.8% |
| 2023 | -$20.25M | -5.7% |
| 2022 | -$19.16M | -47.6% |
| 2021 | -$12.99M | -52.8% |
| 2020 | -$8.50M | +34.8% |
| 2019 | -$13.04M | -64.9% |
| 2018 | -$7.91M | +51.0% |
| 2017 | -$16.14M | +1.3% |
| 2016 | -$16.35M | +40.5% |
| 2015 | -$27.50M | +23.8% |
| 2014 | -$36.10M | +25.1% |
| 2013 | -$48.20M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.70M | -81.9% | -43.9% |
| June 30, 2025 | -$6.05M | -16.7% | -18.7% |
| March 31, 2025 | -$5.09M | -4.7% | -6.5% |
| September 30, 2024 | -$4.78M | +28.1% | +7.7% |
| June 30, 2024 | -$5.18M | +7.8% | -6.5% |
| March 31, 2024 | -$4.87M | -8.1% | +26.9% |
| September 30, 2023 | -$6.65M | -56.2% | -18.4% |
| June 30, 2023 | -$5.62M | -78.3% | -24.9% |
- vTv Therapeutics Inc. showed a decrease of -46.1% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, vTv Therapeutics Inc.’s net income has grown by 44.0% (from -$48.20 million to -$26.97 million).
- The most recent figure is from vTv Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: